These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
133 related articles for article (PubMed ID: 8673104)
21. A genetic therapy for familial hypercholesterolemia. Dichek DA; Bratthauer GL; Beg ZH; Newman KD; Anderson KD; Zwiebel JA; Hoeg JM; Anderson WF Trans Assoc Am Physicians; 1990; 103():73-9. PubMed ID: 2132544 [TBL] [Abstract][Full Text] [Related]
22. Prolonged correction of hyperlipidemia in mice with familial hypercholesterolemia using an adeno-associated viral vector expressing very-low-density lipoprotein receptor. Chen SJ; Rader DJ; Tazelaar J; Kawashiri M; Gao G; Wilson JM Mol Ther; 2000 Sep; 2(3):256-61. PubMed ID: 10985956 [TBL] [Abstract][Full Text] [Related]
24. [Perspective of gene therapy in hyperlipoproteinemia]. Ishibashi S; Yamada N Nihon Rinsho; 1994 Dec; 52(12):3303-8. PubMed ID: 7853727 [TBL] [Abstract][Full Text] [Related]
25. Use of the denaturing gradient gel electrophoresis (DGGE) method for mutational screening of patients with familial hypercholesterolaemia (FH) and Familial defective apolipoprotein B100 (FDB). Azian M; Hapizah MN; Khalid BA; Khalid Y; Rosli A; Jamal R Malays J Pathol; 2006 Jun; 28(1):7-15. PubMed ID: 17694954 [TBL] [Abstract][Full Text] [Related]
26. Sustained expression of human apo A-I following adenoviral gene transfer in mice. De Geest B; Van Linthout S; Collen D Gene Ther; 2001 Jan; 8(2):121-7. PubMed ID: 11313781 [TBL] [Abstract][Full Text] [Related]
27. Gene therapy: prospects for treatment of liver disease. Sandig V; Hofmann C; Löser P; Jennings G; Strauss M Z Gastroenterol; 1996 Jun; 34 Suppl 3():25-6. PubMed ID: 8767451 [TBL] [Abstract][Full Text] [Related]
28. Variability of adenovirus receptor density influences gene transfer efficiency and therapeutic response in head and neck cancer. Li D; Duan L; Freimuth P; O'Malley BW Clin Cancer Res; 1999 Dec; 5(12):4175-81. PubMed ID: 10632357 [TBL] [Abstract][Full Text] [Related]
29. [Identification of a novel mutation at the point of low density lipoprotein receptor gene from a subject with familial hypercholesterolemia]. Liu YR; Tao QM; Chen JZ; Tao M; Guo XG; Shang YP; Zhu JH; Zhang FR; Zheng LR; Wang XX Sheng Li Xue Bao; 2004 Oct; 56(5):566-72. PubMed ID: 15497035 [TBL] [Abstract][Full Text] [Related]
30. Interaction between the LDL-receptor gene bearing a novel mutation and a variant in the apolipoprotein A-II promoter: molecular study in a 1135-member familial hypercholesterolemia kindred. Takada D; Emi M; Ezura Y; Nobe Y; Kawamura K; Iino Y; Katayama Y; Xin Y; Wu LL; Larringa-Shum S; Stephenson SH; Hunt SC; Hopkins PN J Hum Genet; 2002; 47(12):656-64. PubMed ID: 12522687 [TBL] [Abstract][Full Text] [Related]
31. Transient depletion of CD4 lymphocyte improves efficacy of repeated administration of recombinant adenovirus in the ornithine transcarbamylase deficient sparse fur mouse. Ye X; Robinson MB; Pabin C; Batshaw ML; Wilson JM Gene Ther; 2000 Oct; 7(20):1761-7. PubMed ID: 11083498 [TBL] [Abstract][Full Text] [Related]
32. Large heterogeneity of mutations in the gene encoding the low-density lipoprotein receptor in subjects with familial hypercholesterolaemia. Muller PY; Miserez AR Atheroscler Suppl; 2004 Dec; 5(5):1-5. PubMed ID: 15556092 [TBL] [Abstract][Full Text] [Related]
33. Endotoxin suppresses mouse hepatic low-density lipoprotein-receptor expression via a pathway independent of the toll-like receptor 4. Liao W; Rudling M; Angelin B Hepatology; 1999 Nov; 30(5):1252-6. PubMed ID: 10534347 [TBL] [Abstract][Full Text] [Related]
34. Improving lipoprotein profiles by liver-directed gene transfer of low density lipoprotein receptor gene in hypercholesterolaemia mice. Ou H; Zhang Q; Zeng J J Genet; 2016 Jun; 95(2):311-6. PubMed ID: 27350674 [TBL] [Abstract][Full Text] [Related]
35. [Liver cell gene therapy--perspectives after a heroic start]. Rüger R Fortschr Med; 1995 Aug; 113(24):341. PubMed ID: 7590553 [No Abstract] [Full Text] [Related]
36. Nonphysiological overexpression of low-density lipoprotein receptors causes pathological intracellular lipid accumulation and the formation of cholesterol and cholesteryl ester crystals in vitro. Heeren J; Steinwaerder DS; Schnieders F; Cichon G; Strauss M; Beisiegel U J Mol Med (Berl); 1999 Oct; 77(10):735-43. PubMed ID: 10606209 [TBL] [Abstract][Full Text] [Related]
38. Frontiers in gene therapy: LDL receptor replacement for hypercholesterolemia. Grossman M; Wilson JM J Lab Clin Med; 1992 May; 119(5):457-60. PubMed ID: 1583401 [No Abstract] [Full Text] [Related]
39. Sleeping Beauty Transposon Vectors in Liver-directed Gene Delivery of LDLR and VLDLR for Gene Therapy of Familial Hypercholesterolemia. Turunen TA; Kurkipuro J; Heikura T; Vuorio T; Hytönen E; Izsvák Z; Ylä-Herttuala S Mol Ther; 2016 Mar; 24(3):620-35. PubMed ID: 26670130 [TBL] [Abstract][Full Text] [Related]
40. Adenovirus-mediated correction of the genetic defect in hepatocytes from patients with familial hypercholesterolemia. Kozarsky K; Grossman M; Wilson JM Somat Cell Mol Genet; 1993 Sep; 19(5):449-58. PubMed ID: 8291022 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]